Stay updated on Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial
Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedMajor change: version bump to v3.2.0 and an important operating-status notice about government funding and NIH Clinical Center, directing users to official sources.SummaryDifference9%

- Check28 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

- Check43 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2 and the Back to Top element was removed; no other core content, pricing, stock, or time-slot information appears to have changed.SummaryDifference0.5%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.5%

- Check57 days agoChange DetectedThe web page has added a facility name and location details, while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.SummaryDifference62%

- Check71 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.